Arseus NV (RCUS.BR)
14 Mar 2014
|Market Cap (Mil.):||€1,081.55|
|Shares Outstanding (Mil.):||31.36|
BRUSSELS, Feb 7 - Belgium's Arseus forecast further earnings growth in 2014 and said it would divest all of its lower-margin dental and medical supplies units over the course of the year.
BRUSSELS, Feb 7 - Medical and pharmaceutical supplies group Arseus forecast further growth of sales and profit margins in 2014, after increasing its recurring core profit by almost a third in 2013.
BRUSSELS, Feb 7 - Arseus NV : * Arseus achieves turnover growth of 18.6 pct and realises organic growth of 12.6 pct * Says EBITDA increased 30.5 pct to EUR 88.0 million * Says turnover increased 14.4 pct to EUR 386.1 million * Says divestment of all remaining dental and medical activities in 2014 * Says dividend proposal for 2013: EUR 0.72 per share * Says outlook 2014: turnover of at least EUR 480 million with an REBITDA margin of 26 pct * Says Fagron has signed an agreement in
BRUSSELS, Jan 6 - Belgian healthcare group Arseus has sold several small units of its healthcare supplies business to U.S. group Henry Schein for 50 million euros ($68.07 million), the company said on Monday.
BRUSSELS, Jan 6 - Arseus NV : * Says co divests dental distribution, lab and software activities to Henry Schein * Says total cash consideration of EUR 50 million * Expects news regarding remaining activities in healthcare solutions, healthcare specialties in semester of 2014
BRUSSELS, Nov 7 - Belgian medical equipment company Arseus has bought a pharmaceutical software company in Brazil and sold its dental distribution activities in France, it said on Thursday.
BRUSSELS, Oct 8 - Belgian medical equipment company Arseus kept its outlook for 2013, after sales rose by 10.9 percent in the third quarter.
Earnings vs. Estimates
Analyst Research Reports
Arseus NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Directors Deals Ltd.